Deep Dive: Post-Cardiac Arrest Online-Targeted Temperature Management: What Now?

Video Transcription

Video Summary

The speaker begins by introducing the topic of post-arrest care and their talk on targeted temperature management (TTM) after cardiac arrest. They discuss their own research and affiliations before stating that there is still much to learn about the best approach for TTM. The speaker then outlines the objectives of the talk, including discussing the mechanisms and preclinical evidence supporting the use of TTM, providing an overview of clinical trials conducted in this area, discussing the variability in results, and exploring future directions.<br /><br />They explain that after cardiac arrest, the brain undergoes a cascade of inflammatory and cell death processes, exacerbated by the restoration of blood flow. TTM aims to protect the brain from these insults by reducing metabolic needs, decreasing acidosis, promoting pro-survival pathways, and reducing inflammation. Preclinical studies in animals have shown a beneficial effect of TTM on neurological outcomes after cardiac arrest.<br /><br />The speaker then discusses the key clinical trials conducted in this area. The Bernard and HACCA trials found an increase in survival and neurological outcomes with hypothermia compared to normothermia. However, subsequent trials, such as the TTM and TTM-2 trials, did not find a difference between hypothermia and normothermia in terms of survival or neurological outcomes. The Hyperion study found a higher percentage of survivors with a favorable neurological outcome with hypothermia in non-shockable cardiac arrest patients. The Warfarin study, conducted in in-hospital cardiac arrest patients, did not find a difference between hypothermia and normothermia in terms of survival.<br /><br />The speaker then discusses potential interpretations of the variability in trial results, including the concept of secular trends and the need for larger trials to detect clinically meaningful differences. They also highlight the importance of understanding the mechanisms, dose, therapeutic window, patient phenotypes, biomarkers, and feasibility of implementing TTM in clinical practice.<br /><br />In conclusion, the speaker suggests actively preventing fever in post-cardiac arrest patients and highlights the need for ongoing research and multidisciplinary engagement to better understand personalized approaches to TTM. They emphasize the importance of standardization and data collection for quality improvement in post-arrest care.

Keywords

post-arrest care

TTM

neurological outcomes

clinical trials

hypothermia

normothermia

fever prevention

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.